EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Euglycemic Ketoacidosis From Semaglutide in a Patient Without Diabetes

Nikhil Sood iD, Ojas Bansal, Rohini Garg, Abhinav Hoskote

JCEM Case Reports · 14.08.2024 · 2 (9)

DOI: 10.1210/jcemcr/luae156 ↗

Kurz gefasst

Fallbericht in der Zeitschrift JCEM Case Reports, online erschienen am 30.08.2024. Verfasst von Nikhil Sood und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hospital Medicine, Banner Health, Gilbert, AZ 85234, USA. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Euglycemic ketoacidosis is a medical emergency characterized by euglycemia, metabolic acidosis, and ketonemia. It is a well-recognized adverse event in patients with diabetes taking sodium-glucose cotransporter-2 inhibitors. However, little has been reported about euglycemic ketoacidosis using glucagon-like peptide-1 (GLP-1) receptor agonists like semaglutide. We present a case of euglycemic ketoacidosis in a young female without diabetes who was taking semaglutide for weight loss for the last 7 months. She was treated with bicarbonate-containing dextrose infusion, which improved the ketoacidosis rapidly. The incidence of euglycemic ketoacidosis will likely increase with the increasing use of GLP-1 inhibitors, and recognizing the signs and symptoms of this life-threatening condition is essential to treat it effectively. Our literature search identified 1 reported case of euglycemic ketoacidosis in a patient without diabetes associated with tirzepatide but none with semaglutide.

Schlagwörter

Stichwörter der Autor:innen

GLP-1 agonistWegovyeuglycemic ketoacidosispatients without diabetessemaglutide

Autor:innen und Institutionen

  • Department of Hospital Medicine, Banner Health, Gilbert, AZ 85234, USA.
  • Department of Cardiology, Banner Health, Mesa, AZ 85202, USA.
  • Department of Internal Medicine, CHI Health Mercy Hospital, Council Bluffs, IA 51503, USA.
  • Department of Internal Medicine, WellSpan York Hospital, York, PA 17403, USA.

ORCID-Profile: Nikhil Sood

Zitieren

APA

Sood, N., Bansal, O., Garg, R., & Hoskote, A. (2024). Euglycemic Ketoacidosis From Semaglutide in a Patient Without Diabetes. JCEM Case Reports, 2(9). https://doi.org/10.1210/jcemcr/luae156

Vancouver

Sood N, Bansal O, Garg R, Hoskote A. Euglycemic Ketoacidosis From Semaglutide in a Patient Without Diabetes. JCEM Case Reports. 2024;2(9). doi:10.1210/jcemcr/luae156

BibTeX
@article{Sood2024,
  author = {Sood, Nikhil and Bansal, Ojas and Garg, Rohini and Hoskote, Abhinav},
  title = {Euglycemic Ketoacidosis From Semaglutide in a Patient Without Diabetes},
  journal = {JCEM Case Reports},
  year = {2024},
  volume = {2},
  number = {9},
  doi = {10.1210/jcemcr/luae156}
}
Kostenlos starten →